These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34714068)

  • 1. Advances in Field Detection Based on CRISPR/Cas System.
    Yuan M; Ding R; Chen S; Duan G
    ACS Synth Biol; 2021 Nov; 10(11):2824-2832. PubMed ID: 34714068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of the CRISPR-Cas system for infectious disease diagnostics.
    Li P; Wang L; Yang J; Di LJ; Li J
    Expert Rev Mol Diagn; 2021 Jul; 21(7):723-732. PubMed ID: 33899643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bio-SCAN: A CRISPR/dCas9-Based Lateral Flow Assay for Rapid, Specific, and Sensitive Detection of SARS-CoV-2.
    Ali Z; Sánchez E; Tehseen M; Mahas A; Marsic T; Aman R; Sivakrishna Rao G; Alhamlan FS; Alsanea MS; Al-Qahtani AA; Hamdan S; Mahfouz M
    ACS Synth Biol; 2022 Jan; 11(1):406-419. PubMed ID: 34939798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-based tools: Alternative methods for the diagnosis of COVID-19.
    Palaz F; Kalkan AK; Tozluyurt A; Ozsoz M
    Clin Biochem; 2021 Mar; 89():1-13. PubMed ID: 33428900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19.
    Vatankhah M; Azizi A; Sanajouyan Langeroudi A; Ataei Azimi S; Khorsand I; Kerachian MA; Motaei J
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):225-241. PubMed ID: 33245685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-based systems for sensitive and rapid on-site COVID-19 diagnostics.
    Soh JH; Balleza E; Abdul Rahim MN; Chan HM; Mohd Ali S; Chuah JKC; Edris S; Atef A; Bahieldin A; Ying JY; Sabir JSM
    Trends Biotechnol; 2022 Nov; 40(11):1346-1360. PubMed ID: 35871983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.
    Zhan Y; Li XP; Yin JY
    Int J Biol Sci; 2021; 17(8):2080-2088. PubMed ID: 34131407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Visual CRISPR Assay: A Naked-Eye Colorimetric Detection Method for Nucleic Acids Based on CRISPR/Cas12a and a Convolutional Neural Network.
    Xie S; Tao D; Fu Y; Xu B; Tang Y; Steinaa L; Hemmink JD; Pan W; Huang X; Nie X; Zhao C; Ruan J; Zhang Y; Han J; Fu L; Ma Y; Li X; Liu X; Zhao S
    ACS Synth Biol; 2022 Jan; 11(1):383-396. PubMed ID: 34937346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
    Ali Z; Aman R; Mahas A; Rao GS; Tehseen M; Marsic T; Salunke R; Subudhi AK; Hala SM; Hamdan SM; Pain A; Alofi FS; Alsomali A; Hashem AM; Khogeer A; Almontashiri NAM; Abedalthagafi M; Hassan N; Mahfouz MM
    Virus Res; 2020 Oct; 288():198129. PubMed ID: 32822689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples.
    Liang J; Teng P; Xiao W; He G; Song Q; Zhang Y; Peng B; Li G; Hu L; Cao D; Tang Y
    J Nanobiotechnology; 2021 Sep; 19(1):273. PubMed ID: 34496881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification-free RNA detection with CRISPR-Cas13.
    Shinoda H; Taguchi Y; Nakagawa R; Makino A; Okazaki S; Nakano M; Muramoto Y; Takahashi C; Takahashi I; Ando J; Noda T; Nureki O; Nishimasu H; Watanabe R
    Commun Biol; 2021 Apr; 4(1):476. PubMed ID: 33875803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Based Diagnostics and Microfluidics for COVID-19 Point-of-Care Testing: A Review of Main Applications.
    Nafian F; Nafian S; Kamali Doust Azad B; Hashemi M
    Mol Biotechnol; 2023 Apr; 65(4):497-508. PubMed ID: 36183037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive and Easy-Read CRISPR Strip for COVID-19 Rapid Point-of-Care Testing.
    Li H; Dong X; Wang Y; Yang L; Cai K; Zhang X; Kou Z; He L; Sun S; Li T; Nie Y; Li X; Sun Y
    CRISPR J; 2021 Jun; 4(3):392-399. PubMed ID: 34152219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens.
    Nimsamer P; Mayuramart O; Rattanaburi S; Chantaravisoot N; Saengchoowong S; Puenpa J; Poovorawan Y; Payungporn S
    J Virol Methods; 2021 Apr; 290():114092. PubMed ID: 33539846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CRISPR-based molecular diagnostics: a review].
    Sun W; Huang X; Wang X
    Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):60-73. PubMed ID: 36738201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus detection via programmable Type III-A CRISPR-Cas systems.
    Sridhara S; Goswami HN; Whyms C; Dennis JH; Li H
    Nat Commun; 2021 Sep; 12(1):5653. PubMed ID: 34580296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas systems for diagnosing infectious diseases.
    Kostyusheva A; Brezgin S; Babin Y; Vasilyeva I; Glebe D; Kostyushev D; Chulanov V
    Methods; 2022 Jul; 203():431-446. PubMed ID: 33839288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms.
    Aquino-Jarquin G
    Drug Discov Today; 2021 Aug; 26(8):2025-2035. PubMed ID: 34147688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.